Assessment of the Real-World Safety Profile of Vedolizumab Using the United States Food and Drug Administration Adverse Event Reporting System
PLoS ONE - United States
doi 10.1371/journal.pone.0225572
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 4, 2019
Authors
Publisher
Public Library of Science (PLoS)